News - Pierre Fabre

Filter

Current filters:

Pierre Fabre

Popular Filters

US FDA approves Pierre Fabre’s Hemangeol for infantile hemangioma

US FDA approves Pierre Fabre’s Hemangeol for infantile hemangioma

18-03-2014

Pierre Fabre Dermatologie has obtained marketing authorization from the US Food and Drug Administration…

DermatologicalsHemangeolNorth AmericaPharmaceuticalPierre FabreRegulationUSA

UK’s Redx Pharma signs oncology collaboration with Pierre Fabre

UK’s Redx Pharma signs oncology collaboration with Pierre Fabre

07-03-2014

UK-based drug discovery company Redx Pharma and privately-owned French health care company Pierre Fabre…

FranceOncologyPharmaceuticalPierre FabreRedx PharmaResearchUK

Aurigene and Pierre Fabre announce licensing agreement for novel immunotherapy

Aurigene and Pierre Fabre announce licensing agreement for novel immunotherapy

13-02-2014

Privately-owned Pierre Fabre and Aurigene, a leading Indian biotech company, have entered into an agreement…

Aurigene DiscoveryBiotechnologyFranceIndiaLicensingOncologyPierre Fabre

Forest debuts MMD drug Fetzima in US pharmacies

19-12-2013

US drugmaker Forest Laboratories says that Fetzima (levomilnacipran ER capsules) is now available in…

FetzimaForest LaboratoriesMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalPierre FabreUSA

Forest Labs and Fabre's MMD drug gains FDA approval

26-07-2013

US drugmaker Forest Laboratories (NYSE: FRX) and France-based independent Pierre Fabre Laboratories have…

FetzimaForest LaboratorieslevomilnacipranNeurologicalNorth AmericaPharmaceuticalPierre FabreRegulation

Forest Labs and Pierre Fabre's levomilnacipran positive in Ph III

07-03-2012

US drugmaker Forest Laboratories (NYSE: FRX) and France-based Pierre Fabre have announced positive top-line…

Forest LaboratorieslevomilnacipranNeurologicalPharmaceuticalPierre FabreResearch

Back to top